Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
02/2012
02/15/2012CN102356082A 3, 3' -spiroindolinone derivatives as anticancer agents
02/15/2012CN102356081A Bicyclic compounds for the reduction of beta-amyloid production
02/15/2012CN102356075A Compositions and methods for inhibition of the jak pathway
02/15/2012CN102351907A Method for synthesizing metal N-heterocyclic carbene complex
02/15/2012CN102351859A Antibiotic Pseudonocardian A and Pseudonocardian B, its preparation method thereof and its application in preparation of antibiotics and antitumor drug
02/15/2012CN102351858A High selectivity method for synthesizing moxifloxacin
02/15/2012CN102349940A Process for preparing thermopsis lanceolate total alkaloids and several high-purity medicinal substances
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114867 Oxazolidinone antibiotic derivatives
02/14/2012CA2536429C 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative
02/09/2012WO2012019003A1 Substituted indole and azaindole oxoacetyl piperazinamide derivatives
02/09/2012WO2012018909A1 Fused heterocyclic compounds
02/09/2012WO2012018058A1 Fused heterocyclic ring compound
02/09/2012WO2012017842A1 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device
02/09/2012WO2012016993A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
02/09/2012WO2012016849A1 Process for the homogeneous hydrogenation of (poly)unsaturated hydrocarbons
02/09/2012WO2011133637A3 Compounds and methods for kinase modulation, and indications therefor
02/09/2012US20120035409 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
02/09/2012US20120035370 Azaindazole Compounds As CCR1 Receptor Antagonists
02/09/2012US20120035351 Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors
02/09/2012US20120035209 Hydroxy Substituted 1H-Imidazopyridines and Methods
02/09/2012US20120035208 Pyrazolopyridine pi3k inhibitor compounds and methods of use
02/09/2012US20120035206 Preparation and application of novel antibacterial and anticancer compounds and their derivatives
02/09/2012US20120035201 Spiroheterocyclic pyrrolidine dione derivatives used as pesticides
02/09/2012US20120035172 Purinone Derivatives as HM74A Agonists
02/09/2012US20120035171 Bicyclic heterocyclyl derivatives as fgfr kinase inhibitors for therapeutic use
02/09/2012US20120035168 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
02/09/2012US20120035167 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
02/09/2012US20120035153 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
02/09/2012US20120035149 Prokineticin Receptor Antagonists And Uses Thereof
02/09/2012US20120034250 Condensed pyrrolopyridine derivative
02/09/2012US20120032158 Charge transport compositions and electronic devices made with such compositions
02/09/2012US20120032121 Metallic composite and composition thereof
02/09/2012DE112010000820T5 Verbindungen für nicht-invasive Messung von Aggregaten von Amyloidpeptiden Compounds for non-invasive measurement of aggregates of amyloid peptides
02/09/2012CA2807498A1 2-substituted-8-alkyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitriles and uses thereof
02/09/2012CA2807093A1 Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase
02/08/2012EP2415773A2 Organic electronic device, compounds for same, and terminal
02/08/2012EP2415771A1 Indolizine derivative and use thereof for medical purposes
02/08/2012EP2415770A1 Lithium derivatives of pyrroloquinoline quinone and preparation method thereof
02/08/2012EP2414360A1 Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds
02/08/2012EP2414359A1 Peri-fused pyrazolo-pyrimidine compounds
02/08/2012EP2414358A1 Substituted tetrahydropyrazolo-pyrido-azepin compounds
02/08/2012EP2414357A1 Pyrazolo-pyrrolopyridine-dione derivatives useful in the treatment of cancer
02/08/2012EP2414356A2 Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
02/08/2012EP2414355A2 Fluorescent cellular markers
02/08/2012EP2414346A1 Autotaxin inhibitors
02/08/2012EP2414334A1 Bridged bicyclic heterocycle derivatives and methods of use thereof
02/08/2012EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors
02/08/2012EP2414328A2 Dihydroorotate dehydrogenase inhibitors
02/08/2012EP2166852B1 Therapeutic pyrazoloquinoline derivatives
02/08/2012EP2086968B1 5-hydroxymethyl-oxazolidin-2-one derivatives
02/08/2012EP1706403B1 Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
02/08/2012EP1509518B1 Calcium receptor modulating agents
02/08/2012CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound
02/08/2012CN102348709A Materials for organic electroluminescence devices
02/08/2012CN102348708A Prodrug forms of kinase inhibitors and their use in therapy
02/08/2012CN102348702A Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
02/08/2012CN102348682A 1,1,1-trifluoro-2-hydroxypropyl compounds
02/08/2012CN102344464A High water-solubility ruthenium metal complex singlet oxygen fluorescent probe, preparation method thereof, and application thereof
02/08/2012CN102344457A Spirocyclic aminoquinolones as gsk-3 inhibitors
02/08/2012CN102344449A Heterocyclic-fused naphthalimide and preparation method and application thereof
02/08/2012CN102344448A Preparation method of antiosteoporosis drug minodronate key intermediate
02/08/2012CN102344447A Moxifloxacin hydrochloride monohydrate crystal form and preparation method thereof
02/08/2012CN101544673B 以不同长度饱和碳链连接的双核联吡啶钌/锇ecl标示物 Dual-core bipyridine ruthenium saturated carbon chains of different lengths connected / osmium ecl markers
02/07/2012US8110683 Piperidinyl compounds that selectively bind integrins
02/07/2012US8110679 Nanofilm and membrane compositions
02/07/2012US8110585 Bicyclic compound and pharmaceutical use thereof
02/07/2012US8110581 Lactam compounds and their use as pharmaceuticals
02/07/2012CA2529269C Improved pharmaceutical drug candidates and methods for preparation thereof
02/07/2012CA2471044C Benzimidazole derivatives and their use as gnrh antagonists
02/02/2012WO2012016217A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012WO2012015723A1 Sulfonamide compounds useful as cyp17 inhibitors
02/02/2012WO2012014466A1 Phenanthroline compound, electron transport material obtained from said compound, and organic thin-film photovoltaic cell comprising said compound
02/02/2012WO2012013716A1 Bicyclic acetyl-coa carboxylase inhibitors
02/02/2012WO2012013643A1 Hetero-bicyclic derivatives as hcv inhibitors
02/02/2012WO2012013343A1 Cis-tetrahydrospiro(cyclohexane-1,1'-pyrido[3,4-b]indol)-4-amine derivatives
02/02/2012WO2011057973A9 Oxazoline derivatives for treatment of cns disorders
02/02/2012US20120029192 Pyrazole Derivatives
02/02/2012US20120029010 Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter
02/02/2012US20120029006 Cis-tetrahydro-spiro(cyclohexane-1,1'-pyrido[3,4-b]indole)-4-amine Compounds
02/02/2012US20120029002 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
02/02/2012US20120028975 Substituted triazolopyridines and analogs thereof
02/02/2012US20120028974 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
02/02/2012US20120028969 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof
02/02/2012US20120028958 5-alkynyl-pyrimidines
02/02/2012US20120028956 Bicyclic mglur5 positive allosteric modulators and methods of making and using same
02/02/2012US20120028954 Substituted Pyridine, Pyridazine, Pyrazine And Pyrimidine Compounds And Methods For Using The Same
02/02/2012US20120028952 5-alkynyl-pyrimidines
02/02/2012US20120028940 Functionally selective azanitrile alpha-2c adrenoreceptor agonists
02/02/2012US20120028939 Substituted naphthyridines and their use as medicaments
02/02/2012US20120028823 pH MODULATION METHOD TO DETECT LIGAND-RECEPTOR BINDING
02/02/2012US20120025697 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device
02/02/2012CA2806633A1 Cis-tetrahydro-spiro(cyclohexane-1,1'-pyrido[3,4-b]indole)-4-amine derivatives
02/02/2012CA2806341A1 Ampk-activating heterocyclic compounds and methods for using the same
02/02/2012CA2805078A1 Imidazole derivatives
02/02/2012CA2805043A1 Hetero-bicyclic derivatives as hcv inhibitors
02/01/2012EP2412714A1 Method for the industrial purification of biologically active phycotoxins
02/01/2012EP2412711A1 Indazolepropionic acid amide compound
02/01/2012EP2412710A1 Fused piperidine compound and pharmaceutical agent comprising same
02/01/2012EP2411389A2 9h-pyrrolo[2,3-b: 5,4-c']dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof